ProfileGDS4132 / 215626_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 64% 64% 53% 44% 55% 65% 60% 69% 40% 44% 25% 27% 29% 28% 25% 28% 48% 41% 31% 26% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101183.83964
GSM201543Muscle PCOS pioglitazone 121172.91464
GSM201544Muscle PCOS pioglitazone 161144.79153
GSM201545Muscle PCOS pioglitazone 201124.06344
GSM201829Muscle PCOS pioglitazone 231159.62355
GSM201830Muscle PCOS pioglitazon 251195.40565
GSM201831Muscle PCOS pioglitazone 271172.80260
GSM201832Muscle PCOS pioglitazone 31198.65669
GSM201833Muscle PCOS pioglitazone 4196.592440
GSM201834Muscle PCOS pioglitazone 81114.12844
GSM201835Muscle PCOS after pioglitazone 10247.112125
GSM201836Muscle PCOS after pioglitazone 12256.46727
GSM201837Muscle PCOS after pioglitazone 16257.446429
GSM201838Muscle PCOS after pioglitazone 20258.768128
GSM201839Muscle PCOS after pioglitazone 23251.889125
GSM201840Muscle PCOS after pioglitazone 25265.583428
GSM201841Muscle PCOS after pioglitazone 272110.55148
GSM201842Muscle PCOS after pioglitazone 3287.725941
GSM201843Muscle PCOS after pioglitazone 4273.905731
GSM201844Muscle PCOS after pioglitazone 8255.587626